Mike Rossi | Vice President, Translational Science and Multi-Modal RWE Solutions
ConcertAI

Michael Rossi, PhD, FACMG is VP of Translational Science & Multi-Modal Real World Evidence Solutions at ConcertAI. Prior to ConcertAI, Mike was the Division Head of Molecular Oncology for Solid Tumors at Sema4 and Associate Professor in the Department of Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York.  Mike has extensive expertise in genomics applications for clinical diagnostics, cancer research, and oncology clinical trials, authoring/co-authoring over 65 peer review publications focusing primarily on genomic mechanisms that drive human cancers and response to therapy. At Sema4, he developed a New York State validated comprehensive tumor/normal whole exome/whole transcriptome clinical diagnostic assay for all cancer types that was integrated with real world clinical data from Mount Sinai and pediatric & community practice cancer centers. Prior to Sema4, he was Assistant Professor at Emory University in the Departments of Radiation Oncology, Pathology & Laboratory Medicine where he developed many of the first molecular and NGS based clinical & research assays for solid tumors and hematological malignancies. Mike is board certified in Clinical Molecular Genetics and Clinical Cytogenetics, from the American Board of Medical Genetics. He received his PhD in Genetics and Developmental Biology from West Virginia University & his postdoctoral training includes a Fellowship in Cancer Genetics at Roswell Park Cancer Institute and Clinical Molecular Genetics & Cytogenetics Fellowships in the Department of Genetics at Yale University.